HOME

Health, Medicine and Therapeutics (ISSN Print: 3079-5079, ISSN Online: 3079-5087) is an international, peer-reviewed Open Access (OA) journal committed to advancing cutting-edge research, clinical innovation, and evidence-based practices across the full spectrum of health sciences. The journal serves as a pivotal platform for disseminating transformative knowledge that bridges basic medical research, clinical applications, and public health strategies. By fostering interdisciplinary collaboration, it aims to address global health challenges, improve patient outcomes, and promote equitable access to medical advancements.

Scope and Topics
The journal welcomes submissions spanning ​all domains of health, medicine, and therapeutics, with a focus on scientific rigor, translational impact, and societal relevance. Key areas include but are not limited to:

  • ​Core Medical Sciences:
    • Molecular Medicine, Genomics, and Precision Therapeutics
    • Pathophysiology, Immunology, and Infectious Disease Research
    • Pharmacology, Drug Development, and Toxicology
    • Neuroscience, Endocrinology, and Metabolic Disorders
  • ​Clinical and Translational Research:
    • Clinical Trials, Epidemiology, and Evidence-Based Practice
    • Surgical Innovations, Rehabilitation Sciences, and Regenerative Medicine
    • Oncology, Cardiology, Neurology, and Multidisciplinary Care Models
    • AI-Driven Diagnostics, Digital Health Technologies, and Telemedicine
  • ​Public Health and Global Health:
    • Health Policy, Health Economics, and Healthcare Systems Analysis
    • Preventive Medicine, Vaccinology, and Pandemic Preparedness
    • Social Determinants of Health, Health Equity, and Community Interventions
    • Environmental Health, Occupational Medicine, and Climate-Related Health Risks
  • ​Emerging Frontiers:
    • CRISPR and Gene Therapy Advancements
    • Nanomedicine, Biomaterials, and Targeted Drug Delivery
    • Integrative Medicine, Traditional Healing Practices, and Holistic Care
    • Ethical Issues in Medical Research and Biotechnology

Journal Features

  1. ​Open Access: Freely accessible content under a ​Creative Commons CC BY 4.0 license, ensuring global reach and unrestricted knowledge sharing.
  2. ​Rigorous Peer Review: Double-blind review process to uphold scientific validity, originality, and ethical standards.
  3. ​Translational Focus: Prioritizes research that bridges laboratory discoveries to clinical practice and public health solutions.
  4. ​Global Collaboration: Encourages submissions from diverse regions, particularly low-resource settings and underrepresented populations.
  5. ​Diverse Formats: Publishes original research articles, systematic reviews, clinical case studies, methodological papers, and policy commentaries.

Target Audience
The journal engages medical researchers, clinicians, public health professionals, pharmacologists, biomedical engineers, policymakers, and educators dedicated to advancing health sciences and improving global well-being.

Submission Guidelines
Authors worldwide are invited to submit ​unpublished, original manuscripts through the journal’s online submission system. Submissions must adhere to ethical guidelines (e.g., Declaration of Helsinki, informed consent) and follow the journal’s formatting template (available on the website). Accepted contributions include:

  • Original empirical studies (basic, clinical, or population-based)
  • Comprehensive reviews and meta-analyses
  • Clinical trial protocols and results
  • Health technology assessments and cost-effectiveness analyses
  • Ethical debates and policy recommendations

Multilingual Support: Manuscripts in languages other than English are accepted if accompanied by a detailed English abstract.

Publication and Accessibility

  • ​Immediate OA Access: All articles are freely available upon publication to maximize impact and accessibility.
  • ​Rapid Publication: Streamlined editorial process for swift dissemination of urgent health-related findings.

Health, Medicine and Therapeutics stands at the forefront of medical innovation, uniting global experts to tackle pressing health challenges through science, ethics, and collaboration. Join us in shaping a healthier, more equitable future for all.

Erytis Publishing Limited

Always Open for Submissions

Work at your own pace with no cutoff date for submitting your work

Peer-review

Robust peer-review ensures your work is suitable for publication and of interest to the scientific community

Online First

Early online publication after acceptance assures research is made available to the scientific community without delay

Open Access

Your work will be permanently available online, free to download, share and read

CC BY 40 Copyright © 2025 by authors and Erytis Publishing Limited.

Copyright and Licensing

Articles published by Erytis Publishing Limited journals are under a Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) license, allowing users to copy, distribute and transmit an article and adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed. This ensures that the work gets maximum exposure, and the authors receive due credit for their contribution.

Copyright on any open access article published by Erytis Publishing Limited is retained by the author(s). Authors grant Erytis Publishing Limited a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its original authors, citation details and publisher are identified.

 

elibrary elibrary